Browsing Over 138 Presentations

Sort By
Educational session

PARP inhibitors: Mechanism of resistance and how to overcome

Session Name
Treatment of ovarian cancer in 2023 (ID 2)
Speakers
  • Iain McNeish (London, United Kingdom)
Date
Thu, 23.02.2023
Time
08:30 - 09:50
Room
Auditorium 113
Duration
15 Minutes
Multidisciplinary Tumour Board

State-of-the-art management in carcinosarcoma: From the biology to treatment

Session Name
Rare cancers (ID 16)
Speakers
  • Ignacio Romero (Valencia, Spain)
Date
Fri, 24.02.2023
Time
14:30 - 15:50
Room
Auditorium 113
Duration
20 Minutes
Poster Display session

Endometrial cancer

Session Name
Poster Display session (ID 10)
Date
Thu, 23.02.2023
Time
13:00 - 13:45
Room
Exhibition and Poster area
Educational session

Beyond immunotherapy: What is the role of HER2, p53 and other molecular targets in the recurrent/metastatic endometrial cancer treatment landscape?

Session Name
Endometrial cancer (ID 13)
Speakers
  • Mansoor Raza Mirza (Copenhagen, Denmark)
Date
Fri, 24.02.2023
Time
10:15 - 11:35
Room
Auditorium 113
Duration
15 Minutes
Educational session

Q&A

Session Name
Is cervical cancer still an orphan disease? (ID 12)
Date
Fri, 24.02.2023
Time
08:30 - 09:50
Room
Auditorium 113
Duration
15 Minutes
Educational session

Introduction

Session Name
Is cervical cancer still an orphan disease? (ID 12)
Speakers
  • Kosei Hasegawa (Saitama, Japan)
Date
Fri, 24.02.2023
Time
08:30 - 09:50
Room
Auditorium 113
Duration
5 Minutes
Educational session

Understanding the basics: Structure, key properties, mechanism of action, optimal diagnostic test to determine the target

Session Name
ADCs in gynaecological cancers (ID 7)
Speakers
  • Kathleen N. Moore (Oklahoma City, Oklahoma, United States of America)
Date
Thu, 23.02.2023
Time
16:30 - 17:50
Room
Auditorium 113
Duration
15 Minutes
Poster Display session

General interest

Session Name
Poster Display session (ID 10)
Date
Thu, 23.02.2023
Time
13:00 - 13:45
Room
Exhibition and Poster area
Controversy session

Introduction and first vote

Session Name
How hot is HIPEC treatment in ovarian cancer? (ID 6)
Speakers
  • Robert L. Coleman (The Woodlands, TX, United States of America)
Date
Thu, 23.02.2023
Time
15:00 - 16:00
Room
Auditorium 113
Duration
10 Minutes
ESMO Colloquium

Research insights: New immunotherapy combinations in clinical development for gynecological malignancies

Session Name
ESMO Colloquium supported by Eisai Europe Ltd. - Management of patients with advanced endometrial cancer in the era of molecular oncology and immunotherapy (ID 8)
Speakers
  • Alexandra Leary (Villejuif, France)
Date
Thu, 23.02.2023
Time
18:00 - 19:00
Room
Auditorium 113
Duration
15 Minutes
Special Symposium

Why are we having this Symposium? Recent regulatory actions by FDA/EMEA regarding late-stage approval for PARPi in recurrent ovarian cancer

Session Name
How to interpret overall survival data with PARP inhibitors (ID 3)
Speakers
  • Robert L. Coleman (The Woodlands, TX, United States of America)
Date
Thu, 23.02.2023
Time
10:15 - 11:35
Room
Auditorium 113
Duration
15 Minutes
Multidisciplinary Tumour Board

Which drugs could be relevant for LGSC: The present and future

Session Name
Rare cancers (ID 16)
Speakers
  • Charlie Gourley (Edinburgh, United Kingdom)
Date
Fri, 24.02.2023
Time
14:30 - 15:50
Room
Auditorium 113
Duration
20 Minutes